Conveniently implantable sustained release drug compositions
Details for Australian Patent Application No. 2005292145 (hide)
International Classifications
Event Publications
3 May 2007 PCT application entered the National Phase
PCT publication WO2006/039336 Priority application(s): WO2006/039336
17 February 2011 Application Accepted
Published as AU-B-2005292145
31 March 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 04 Mar 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
21 July 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 Mar 2011
28 July 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005292152-Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors
2005292140-Control console capable of simultaneously controlling plural surgical tools
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser